Both formulations contain the same active ingredient, but they differ in their administration and dosage regimens
A., Khushaish, S., & Luqmani, Y
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
Dans les tudes dinfusion du GLP-1 mentionnes plus tt, on a observ que la molcule activait la sensation de satit, ce qui suggrait un effet thrapeutique possible sur la diminution de lapptit et de lapport calorique
This effect results from delayed gastric emptying, enhanced satiety, and reduced caloric intake rather than increased energy expenditure